Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone in hospitalized patients with multiple sclerosis
IRCT20210707051810N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trazodone in multiple sclerosis (MS), sponsored by Tehran University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
trazodone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20210707051810N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210707051810N1.